REPLIGEN CORP - COMMON STOCK (RGEN)

Q3 2020 13F Holders as of 30 Sep 2020

Type / Class
Equity / COMMON STOCK
Shares outstanding
56,222,082
Total 13F shares
44,707,932
Share change
-313,620
Total reported value
$6,601,225,733
Put/Call ratio
37%
Price per share
$147.54
Number of holders
384
Value change
-$40,211,297
Number of buys
195
Number of sells
170

Institutional Holders of REPLIGEN CORP - COMMON STOCK (RGEN) as of Q3 2020

As of 30 Sep 2020 REPLIGEN CORP - COMMON STOCK (RGEN) had 384 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions held a total of 44,707,932 shares of stock of the company.
Largest 10 holders included BlackRock Inc., VANGUARD GROUP INC, Invesco Ltd., Select Equity Group, L.P., Conestoga Capital Advisors, LLC, FRED ALGER MANAGEMENT, LLC, STATE STREET CORP, ALLIANCEBERNSTEIN L.P., 12 West Capital Management LP, and WELLINGTON MANAGEMENT GROUP LLP.
This table shows 384 institutional shareholders of the security as of 30 Sep 2020.
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.